EVH:NYE-Evolent Health Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 24.57

Change

-0.20 (-0.81)%

Market Cap

N/A

Volume

2.62M

Analyst Target

USD 11.67
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+0.93 (+1.25%)

USD 10.78B
DOCS Doximity Inc

+1.07 (+2.53%)

USD 7.80B
WEAV Weave Communications Inc

+0.02 (+0.14%)

USD 1.02B
MPLN MultiPlan Corporation

+0.59 (+7.17%)

USD 0.14B
AMWL American Well Corp

+0.07 (+0.79%)

USD 0.14B
OWLT Owlet Inc

-0.06 (-1.16%)

USD 0.08B
TDOC Teladoc Inc

+0.07 (+0.74%)

N/A
FOXO FOXO Technologies Inc.

-0.41 (-52.89%)

N/A
PHR Phreesia Inc

-0.24 (-1.13%)

N/A
VEEV Veeva Systems Inc Class A

+6.94 (+3.21%)

N/A

ETFs Containing EVH

ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

-0.41 (-1.22%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -25.61% 20% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -25.61% 20% F 18% F
Trailing 12 Months  
Capital Gain -11.24% 20% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.24% 20% F 20% F
Trailing 5 Years  
Capital Gain 142.79% 100% F 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 142.79% 100% F 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 45.89% 100% F 93% A
Dividend Return 45.89% 100% F 92% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 72.22% 50% F 12% F
Risk Adjusted Return 63.54% 100% F 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.